Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis

BACKGROUND: Novel therapeutic approaches are critically needed for Staphylococcus aureus bloodstream infections (BSIs), particularly for methicillin-resistant S. aureus (MRSA). Exebacase, a first-in-class antistaphylococcal lysin, is a direct lytic agent that is rapidly bacteriolytic, eradicates bio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Invest
Main Authors: Fowler, Vance G., Das, Anita F., Lipka-Diamond, Joy, Schuch, Raymond, Pomerantz, Roger, Jáuregui-Peredo, Luis, Bressler, Adam, Evans, David, Moran, Gregory J., Rupp, Mark E., Wise, Robert, Corey, G. Ralph, Zervos, Marcus, Douglas, Pamela S., Cassino, Cara
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2020
Assuntos:
Clinical Medicine
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7324170/
https://ncbi.nlm.nih.gov/pubmed/32271718
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI136577
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados